Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial

BACKGROUND: There is strong mechanistic evidence to suggest that vitamin D and omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFAs), specifically docosahexaenoic acid (DHA), have the potential to significantly improve the symptoms of autism spectrum disorder (ASD). However, there are no tria...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Mazahery, Hajar, Conlon, Cathryn, Beck, Kathryn L., Kruger, Marlena C., Stonehouse, Welma, Camargo, Carlos A., Meyer, Barbara J., Tsang, Bobby, Mugridge, Owen, von Hurst, Pamela R.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4917935/
https://ncbi.nlm.nih.gov/pubmed/27334138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1428-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky